The Peggy Lillis Foundation's CEO and Co-founder Christian Lillis discusses the organization's initiatives for C diff month, and offers a glimpse of the upcoming Scientific Symposium they are hosting next week.
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.
Cefiderocol MICs fell against Pseudomonas aeruginosa and Klebsiella pneumoniae, and the drug showed marked synergy with LL-37 against resistant Acinetobacter baumannii. Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses her team's findings around this therapy and these pathogens.
PAHO revoked the US measles elimination status this week. Nina Masters, PhD, MPH, offers commentary on the factors leading to it including vaccine hesitancy as well as unintended consequences such as the outbreak-driven spikes in measles titer testing among adults over 50.
Ryan Shields, PharmD, MS, explains how rapid diagnostics, aggressive β-lactam dosing in CRRT, and cefepime-zidebactam fit within the IDSA 2026 guidance on antimicrobial-resistant Gram-negative infections.
The World Health Organization (WHO) confirmed 2 sporadic, camel-linked MERS-CoV infections with both patients recovered and no secondary transmission among 99 traced contacts.